Singapore recalls 3 brands of Losartan medicines

The Health Sciences Authority (HSA) in Singapore has recalled three brands of high blood pressure medicine which contain losartan –Losartas, Losagen and Hyperten, recently.

Seven other brands of losartan medicine approved in Singapore are not affected by the recall. 

About 137,000 patients in Singapore are using the three recalled brands of losartan medicine. Of these, about 130,000 patients have been prescribed Losartas at the public healthcare institutions.

Losartan is a medication used primarily to control high blood pressure. Losartas is prescribed in public healthcare institutions, while Losartas, Losagen and Hyperten are prescribed at private healthcare institutions.

There is no immediate health risk associated with taking the affected brands of medicine. Patients are strongly advised to continue taking their medicine until their healthcare providers arrange for them to stop or switch to suitable alternatives. Patients who are unsure whether they have been using an affected product should contact their healthcare providers.

Register as Visitor to CPhI China 2019!

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.